Literature DB >> 18154614

Special regulatory T-cell review: FOXP3 biochemistry in regulatory T cells--how diverse signals regulate suppression.

Bin Li1, Mark I Greene.   

Abstract

FOXP3 is an acetylated and phosphorylated protein active in human regulatory T cells and forms oligomers which then associate with an even larger molecular complex. FOXP3 actively regulates transcription by recruiting enzymatic co-repressors and/or co-activators. FOXP3 complex ensembles are dynamically regulated by physiological stimuli such as T-cell receptor, IL-2 and proinflammation cytokine signals. Understanding the post-translational modifications of FOXP3 regulated by diverse signals and the biochemistry and structural chemistry of enzymatic proteins in the FOXP3 complex is critical for therapeutically modulating regulatory T cell function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18154614      PMCID: PMC2433283          DOI: 10.1111/j.1365-2567.2007.02774.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors.

Authors:  Bin Wang; Danjuan Lin; Chuan Li; Philip Tucker
Journal:  J Biol Chem       Date:  2003-04-10       Impact factor: 5.157

2.  Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin.

Authors:  O Devergne; M Birkenbach; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  Foxp3 interacts with nuclear factor of activated T cells and NF-kappa B to repress cytokine gene expression and effector functions of T helper cells.

Authors:  Estelle Bettelli; Maryam Dastrange; Mohamed Oukka
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-24       Impact factor: 11.205

4.  Impairment of antigen-presenting cell function by ultraviolet radiation.

Authors:  M I Greene; M S Sy; M Kripke; B Benacerraf
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

5.  CD3-associated heterodimeric polypeptides on suppressor hybridomas define biologically active inhibitory cells.

Authors:  D B Weiner; J Liu; N Hanna; J A Bluestone; J E Coligan; W V Williams; M I Greene
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

Review 6.  Molecular characterization of suppressor T cells.

Authors:  D B Weiner; W V Williams; R M Siegel; S Jerrold-Jones; M I Greene
Journal:  Transplant Proc       Date:  1988-12       Impact factor: 1.066

Review 7.  Helper and suppressor T cell factors.

Authors:  R N Germain; B Benacerraf
Journal:  Springer Semin Immunopathol       Date:  1980-05

8.  The neu oncogene: an erb-B-related gene encoding a 185,000-Mr tumour antigen.

Authors:  A L Schechter; D F Stern; L Vaidyanathan; S J Decker; J A Drebin; M I Greene; R A Weinberg
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

9.  The inhibitory cytokine IL-35 contributes to regulatory T-cell function.

Authors:  Lauren W Collison; Creg J Workman; Timothy T Kuo; Kelli Boyd; Yao Wang; Kate M Vignali; Richard Cross; David Sehy; Richard S Blumberg; Dario A A Vignali
Journal:  Nature       Date:  2007-11-22       Impact factor: 49.962

10.  Monoclonal antibodies identify a cell-surface antigen associated with an activated cellular oncogene.

Authors:  J A Drebin; D F Stern; V C Link; R A Weinberg; M I Greene
Journal:  Nature       Date:  1984 Dec 6-12       Impact factor: 49.962

View more
  11 in total

1.  Thymic changes after chorioamnionitis induced by intraamniotic lipopolysaccharide in fetal sheep.

Authors:  Steffen Kunzmann; Kerstin Glogger; Jasper V Been; Suhas G Kallapur; Ilias Nitsos; Timothy J Moss; Christian P Speer; John P Newnham; Alan H Jobe; Boris W Kramer
Journal:  Am J Obstet Gynecol       Date:  2010-05       Impact factor: 8.661

2.  Adenosine signaling via the adenosine 2B receptor is involved in bronchiolitis obliterans development.

Authors:  Yunge Zhao; Damien J LaPar; John Steidle; Abbas Emaminia; Irving L Kron; Gorav Ailawadi; Joel Linden; Christine L Lau
Journal:  J Heart Lung Transplant       Date:  2010-12       Impact factor: 10.247

Review 3.  Cbl- and Nedd4-family ubiquitin ligases: balancing tolerance and immunity.

Authors:  Denise L Gay; Hilda Ramón; Paula M Oliver
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

Review 4.  Regulation generation: the suppressive functions of human regulatory T cells.

Authors:  Wendy A Goodman; Kevin D Cooper; Thomas S McCormick
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

Review 5.  The dual role of the X-linked FoxP3 gene in human cancers.

Authors:  Margaret Redpath; Bin Xu; Leon C van Kempen; Alan Spatz
Journal:  Mol Oncol       Date:  2011-03-30       Impact factor: 6.603

6.  Metabolic Choice Tunes Foxp3+ Regulatory T Cell Function.

Authors:  Xiaoxia Wang; Hao Cheng; Yige Shen; Bin Li
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Immune regulation by histone deacetylases: a focus on the alteration of FOXP3 activity.

Authors:  Hongtao Zhang; Yan Xiao; Zhiqiang Zhu; Bin Li; Mark I Greene
Journal:  Immunol Cell Biol       Date:  2011-11-29       Impact factor: 5.126

8.  Curcumin improves regulatory T cells in gut-associated lymphoid tissue of colitis mice.

Authors:  Hai-Mei Zhao; Rong Xu; Xiao-Ying Huang; Shao-Min Cheng; Min-Fang Huang; Hai-Yang Yue; Xin Wang; Yong Zou; Ai-Ping Lu; Duan-Yong Liu
Journal:  World J Gastroenterol       Date:  2016-06-21       Impact factor: 5.742

9.  Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model.

Authors:  Ai-Xia Dou; Li-Li Feng; Xiao-Qian Liu; Xin Wang
Journal:  Cell Mol Immunol       Date:  2012-09-24       Impact factor: 11.530

Review 10.  Microenvironment Cell Contribution to Lymphoma Immunity.

Authors:  Deepika Kumar; Mina L Xu
Journal:  Front Oncol       Date:  2018-07-27       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.